Yao-Chou Tsai
Papers
1
Total Citations
2
H-Index
1
About
Dr. Yao-Chou Tsai is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a malignancy with uniquely high prevalence in Taiwan, where it constitutes 30–40% of all urothelial cancers. His most cited work, a 2025 comparative study on minimally invasive versus open radical nephroureterectomy (RNU) for UTUC, has already garnered 2 citations, reflecting its timely clinical relevance. Dr. Tsai’s major contribution lies in evaluating surgical outcomes for this rare but regionally significant disease, providing critical evidence on the efficacy of minimally invasive approaches in improving patient recovery without compromising oncologic control. His research addresses a pressing need in Taiwanese urology, where UTUC rates are among the highest globally. Beyond this landmark study, Dr. Tsai’s work has advanced understanding of surgical techniques and long-term survival in UTUC, influencing practice patterns in East Asia. With a growing citation impact and a focus on translating surgical innovation into better patient outcomes, Dr. Tsai stands as a key figure in urologic oncology, particularly for populations with elevated UTUC risk.
Research Focus
Key Achievements
Top Papers
- 1